Table 2.
Prevalence of rifampicin resistant TB in TB patients based on sex, gender, age, treatment history, and HIV status in Addis Ababa, Ethiopia (N = 1876)
| Variables | RR-TB N (%) | Not RR-TB N (%) | COR (95% CI) | AOR(95%CI) | P Value |
|---|---|---|---|---|---|
| Gender | |||||
| Male | 95 (14.6)% | 1012 (85.8) | reference | ||
| Females | 91 (11.8) | 678 (88.2) | 1.43 (1.06–1.52) | 1.5 (1.10–1.99) | 0.02 |
| Age-group years | |||||
| 0–15 | 8 (7.9) | 93 (92.1) | reference | ||
| 16–30 | 94 (10.9) | 769 (89.1) | 1.421 (0.67–3.02) | ||
| 31–45 | 60 (10.3) | 524(89.7%.) | 1.33 (0.62–2.88) | ||
| 46–60 | 17 (6.8) | 233 (93.2) | 0.85 (0.35–2.03) | ||
| > 61 | 7 (9) | 71 (91) | 1.15 (0.39–3.31) | ||
| TB-treatment history | |||||
| Previously Rx cases | 60 (27.4) | 159 (72.6) | 4.6(3.24–6.49) | 4.7 (3.30–6.75) | 0.001 |
| New cases | 126 (7.6) | 1531 (92.4) | reference | ||
| HIV status | |||||
| Positive | 17 (14.5) | 100 (85.5) | 1.64 (0.956–2.81) | ||
| Negative | 11 (14.3) | 66 (85.7) | 1.61(0.832–3.12) | ||
| Unknown | 158 (9.4) | 1524 (90.6) | reference | ||
HIV human immunodeficiency virus, RR-TB rifampicin resistant tuberculosis, TB Tuberculosis, Rx Treated, COR Crude Odd Ratio, AOR Adjusted Odd Ratio